ST PHI THERAPEUTICS ENGINEERING CELLS FOR CURES
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 May 2022)
What this means for you
This application is over — abandoned 16 May 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87824857
- Mark type
- Design + words
- Filed
- 07 Mar 2018
- Published for opposition
- 12 Feb 2019
- Abandoned
- 16 May 2022
Goods and services
- Class 005 — Pharmaceuticals: bioreagents for diagnostic or therapeutics purpose, and the genetically engineered cells products for treating different human diseases
Owner
- ST Phi Therapeutics, Seattle, WA, US
- ST Phi Therapeutics, Seattle, WA, US
Prosecution history
- 16 May 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 May 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Sept 2021 — SOU EXTENSION 5 GRANTED
- 05 Sept 2021 — SOU EXTENSION 5 FILED
- 05 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 10 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2021 — SOU EXTENSION 4 GRANTED
- 05 Mar 2021 — SOU EXTENSION 4 FILED
- 05 Mar 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Sept 2020 — SOU EXTENSION 3 GRANTED
- 07 Sept 2020 — SOU EXTENSION 3 FILED
- 07 Sept 2020 — SOU TEAS EXTENSION RECEIVED
- 07 Mar 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED